Omicron could disrupt plans for leading drugs against COVID-19
The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they've used to fight COVID-19.
Source: kens5.com
Stay updated with breaking news from James Cutrell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they've used to fight COVID-19.
The omicron variant of the coronavirus makes up nearly 3% of COVID-19 cases in the US. The CDC has detected the new strain in 43 states. Latest news.
For more than a year, antibody drugs from Regeneron and Eli Lilly have been the go-to drugs to keep patients out of the hospital
The shrinking toolbox of treatments is a reminder that the virus still has the upper hand in the U.S.
Omicron May Sideline Two Leading Drugs Against COVID-19.